Sei Investments Co. Raises Position in Corteva, Inc. $CTVA

Sei Investments Co. lifted its position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 2.9% during the first quarter, HoldingsChannel reports. The fund owned 1,572,931 shares of the company’s stock after acquiring an additional 44,197 shares during the quarter. Sei Investments Co.’s holdings in Corteva were worth $131,671,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in CTVA. JPL Wealth Management LLC purchased a new stake in Corteva in the 3rd quarter valued at approximately $25,000. Westfuller Advisors LLC lifted its holdings in shares of Corteva by 2,764.3% in the 1st quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock valued at $34,000 after buying an additional 387 shares during the period. Garton & Associates Financial Advisors LLC purchased a new stake in shares of Corteva in the fourth quarter valued at approximately $27,000. Bank of Jackson Hole Trust purchased a new stake in shares of Corteva in the fourth quarter valued at approximately $28,000. Finally, Cornerstone Financial Management LLC acquired a new position in Corteva during the fourth quarter worth $29,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Get Corteva alerts:

Corteva Trading Up 0.2%

NYSE:CTVA opened at $88.74 on Friday. The company has a market capitalization of $59.35 billion, a PE ratio of 52.20, a price-to-earnings-growth ratio of 2.69 and a beta of 0.56. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $89.39. The stock has a fifty day simple moving average of $81.25 and a 200-day simple moving average of $78.84.

Corteva (NYSE:CTVA – Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the prior year, the company earned $1.13 EPS. The firm’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts expect that Corteva, Inc. will post 3.75 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. The ex-dividend date was Monday, June 1st. Corteva’s payout ratio is currently 42.35%.

Analyst Upgrades and Downgrades

A number of research firms have commented on CTVA. Zacks Research raised Corteva from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. Morgan Stanley upped their price target on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. Royal Bank Of Canada increased their price target on shares of Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a report on Tuesday. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Corteva from $90.00 to $100.00 in a report on Monday, May 11th. Finally, CICC Research increased their target price on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a report on Wednesday, May 13th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $90.19.

Get Our Latest Research Report on CTVA

Corteva Company Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Articles

• Five stocks we like better than Corteva
• Premium Retail’s Stress Test Is Separating Winners From Losers
• D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
• GE Vernova Just Sent a Mixed AI Signal to Investors
• Alphabet Crushed Earnings, But One Number Spooked the Market

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.